Seeing as the company gives you nothing to go on, anyone got a view on short-medium term ebitda margins/operating leverage?
Going through the cost line, I expect most items to increase in line with sales/usage
R&D and admin costs probably flat
This compares to the latest morgans note who have IME generating 14% EBITDA margins in CY23..... seems a stretch but maybe I am missing something